Chapter 3 Neurology Clinical Trials Market: Variables, Trends, & Scope
3.1 Market Segmentation and Scope
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing neurological disease, such as dementia, stroke, and peripheral neuropathy
3.2.1.2 Increasing R&D investments
3.2.1.3 Stringent Regulatory Requirements
3.2.2 Market Restraint Analysis
3.2.2.1 High Failure Rates of Trials
3.2.2.2 Rising Cost of Clinical Trials
3.3 Penetration & Growth Prospect Mapping
3.4 COVID-19 Impact on the Market
3.5 Major Deals and Strategic Alliances Analysis
3.6 Neurology Clinical Trials: Market Analysis Tools
3.6.1 Industry Analysis - Porter’s
3.6.3 PESTEL Analysis
Chapter 4 Neurology Clinical Trials Market: Phase Segment Analysis
4.1 Neurology Clinical Trials Market: Phase Market Share Analysis, 2020 & 2028
4.2 Phase I
4.2.1 Phase I Market, 2016 - 2028 (USD Million)
4.3 Phase II
4.3.1 Phase II Market, 2016 - 2028 (USD Million)
4.4 Phase III
4.4.1 Phase III Market, 2016 - 2028 (USD Million)
4.5 Phase IV
4.5.1 Phase IV Market, 2016 - 2028 (USD Million)
Chapter 5 Neurology Clinical Trials Market: Study Design Segment Analysis
5.1 Neurology Clinical Trials Market: Study Design Market Share Analysis, 2020 & 2028
5.2 Interventional
5.2.1 Interventional Market, 2016 - 2028 (USD Million)
5.3 Observational
5.3.1 Observational Market, 2016 - 2028 (USD Million)
5.4 Expanded Access
5.4.1 Expanded Access Market, 2016 - 2028 (USD Million)
Chapter 6 Neurology Clinical Trials Market: Indication Segment Analysis
6.1 Neurology Clinical Trials: Indication Market Share Analysis, 2020 & 2028
6.2 Epilepsy
6.2.1 Epilepsy Market, 2016 - 2028 (USD Million)
6.3 Parkinson's Disease
6.3.1 Parkinson's Disease Market, 2016 - 2028 (USD Million)
6.4 Huntington's Disease
6.4.1 Huntington's Disease Market, 2016 - 2028 (USD Million)
6.5 Stroke
6.5.1 Stroke Market, 2016 - 2028 (USD Million)
6.6 Traumatic Brain Injury
6.6.1 Traumatic Brain Injury Market, 2016 - 2028 (USD Million)
6.7 Amyotrophic Lateral Sclerosis
6.7.1 Amyotrophic Lateral Sclerosis Market, 2016 - 2028 (USD Million)
6.8 Muscle regeneration
6.8.1 Muscle regeneration Market, 2016 - 2028 (USD Million)
6.9 Others
6.9.1 Others Market, 2016 - 2028 (USD Million)
Chapter 7 Neurology Clinical Trials Market: Regional Analysis
7.1 Neurology Clinical Trials Market: Regional Market Share Analysis, 2020 & 2028
7.2 North America
7.2.1 North America Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.2.3 Canada
7.2.3.1 Canada Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.3 Europe
7.3.1 Europe Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.3.2 U.K.
7.3.2.1 U.K. Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.3.3 Germany
7.3.3.1 Germany Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.3.4 France
7.3.4.1 France Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.3.5 Italy
7.3.5.1 Italy Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.3.6 Spain
7.3.6.1 Spain Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.4.2 Japan
7.4.2.1 Japan Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.4.3 China
7.4.3.1 China Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.4.4 India
7.4.4.1 India Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.4.5 Australia
7.4.5.1Australia Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.5 Latin America
7.5.1 Latin America Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.5.5 Colombia
7.5.5.1 Colombia Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.6 MEA
7.6.1 MEA Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
7.6.4 UAE
7.6.4.1 UAE Neurology Clinical Trials Market, 2016 - 2028 (USD Million)
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Neurology Clinical Trials Market, by region, 2016-2028 (USD Million)
Table 4 Global Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 5 Global Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 6 Global Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 7 North America Neurology Clinical Trials Market, by Country, 2016-2028 (USD Million)
Table 8 North America Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 9 North America Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 10 North America Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 11 U.S. Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 12 U.S. Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 13 U.S. Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 14 Canada Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 15 Canada Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 16 Canada Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 17 Europe Neurology Clinical Trials Market, by Country, 2016-2028 (USD Million)
Table 18 Europe Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 19 Europe Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 20 Europe Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 21 U.K. Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 22 U.K. Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 23 U.K. Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 24 Germany Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 25 Germany Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 26 Germany Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 27 France Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 28 France Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 29 France Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 30 Italy Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 31 Italy Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 32 Italy Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 33 Spain Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 34 Spain Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 35 Spain Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 36 Asia Pacific Neurology Clinical Trials Market, by Country, 2016-2028 (USD Million)
Table 37 Asia Pacific Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 38 Asia Pacific Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 39 Asia Pacific Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 40 India Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 41 India Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 42 India Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 43 Japan Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 44 Japan Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 45 Japan Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 46 China Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 47 China Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 48 China Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 49 Australia Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 50 Australia Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 51 Australia Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 52 South Korea Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 53 South Korea Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 54 South Korea Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 55 Latin America Neurology Clinical Trials Market, by Country, 2016-2028 (USD Million)
Table 56 Latin America Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 57 Latin America Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 58 Latin America Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 59 Brazil Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 60 Brazil Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 61 Brazil Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 62 Mexico Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 63 Mexico Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 64 Mexico Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 65 Argentina Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 66 Argentina Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 67 Argentina Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 68 Colombia Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 69 Colombia Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 70 Colombia Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 71 MEA Neurology Clinical Trials Market, by Country, 2016-2028 (USD Million)
Table 72 MEA Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 73 MEA Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 74 MEA Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 75 South Africa Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 76 South Africa Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 77 South Africa Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 78 South Arabia Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 79 South Arabia Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 80 South Arabia Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
Table 81 UAE Neurology Clinical Trials Market, by Phase, 2016-2028 (USD Million)
Table 82 UAE Neurology Clinical Trials Market, by Study Design, 2016-2028 (USD Million)
Table 83 UAE Neurology Clinical Trials Market, by Indication, 2016-2028 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Secondary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Neurology clinical trials market snapshot (2020)
Fig. 8 Neurology clinical trials market segmentation
Fig. 9 Market driver relevance analysis (Current & future impact)
Fig. 10 Market restraint relevance analysis (Current & future impact)
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Porter’s five forces analysis
Fig. 13 PESTEL analysis
Fig. 14 Neurology clinical trials market phase outlook: Segment dashboard
Fig. 15 Neurology clinical trials market: Phase movement analysis
Fig. 16 Phase I market, 2016-2028 (USD Million)
Fig. 17 Phase II market, 2016-2028 (USD Million)
Fig. 18 Phase III market, 2016-2028 (USD Million)
Fig. 19 Phase IV market, 2016-2028 (USD Million)
Fig. 20 Neurology clinical trials market study design outlook: Segment dashboard
Fig. 21 Neurology clinical trials market: Study Design movement analysis
Fig. 22 Interventional market, 2016-2028 (USD Million)
Fig. 23 Observational market, 2016-2028 (USD Million)
Fig. 24 Expanded access market, 2016-2028 (USD Million)
Fig. 25 Neurology clinical trials market indication outlook: Segment dashboard
Fig. 26 Neurology clinical trials market: Indication movement analysis
Fig. 27 Epilepsy market, 2016-2028 (USD Million)
Fig. 28 Parkinson's disease market, 2016-2028 (USD Million)
Fig. 29 Huntington's disease market, 2016-2028 (USD Million)
Fig. 30 Stroke indication market, 2016-2028 (USD Million)
Fig. 31 Traumatic Brain Injury market, 2016-2028 (USD Million)
Fig. 32 Amyotrophic Lateral Sclerosis market, 2016-2028 (USD Million)
Fig. 33 Muscle regeneration market, 2016-2028 (USD Million)
Fig. 34 Others indication market, 2016-2028 (USD Million)
Fig. 35 Regional market: Key takeaways
Fig. 36 Regional outlook, 2020 & 2028
Fig. 37 North America market, 2016-2028 (USD Million)
Fig. 38 U.S. market, 2016-2028 (USD Million)
Fig. 39 Canada market, 2016-2028 (USD Million)
Fig. 40 Europe market, 2016-2028 (USD Million)
Fig. 41 U.K. market, 2016-2028 (USD Million)
Fig. 42 Germany market, 2016-2028 (USD Million)
Fig. 43 France market, 2016-2028 (USD Million)
Fig. 44 Italy market, 2016-2028 (USD Million)
Fig. 45 Spain market, 2016-2028 (USD Million)
Fig. 46 Asia Pacific market, 2016-2028 (USD Million)
Fig. 47 Japan market, 2016-2028 (USD Million)
Fig. 48 China market, 2016-2028 (USD Million)
Fig. 49 India market, 2016-2028 (USD Million)
Fig. 50 Australia market, 2016-2028 (USD Million)
Fig. 51 South Korea market, 2016-2028 (USD Million)
Fig. 52 Latin America market, 2016-2028 (USD Million)
Fig. 53 Brazil market, 2016-2028 (USD Million)
Fig. 54 Mexico market, 2016-2028 (USD Million)
Fig. 55 Argentina market, 2016-2028 (USD Million)
Fig. 56 Colombia market, 2016-2028 (USD Million)
Fig. 57 MEA market, 2016-2028 (USD Million)
Fig. 58 South Africa market, 2016-2028 (USD Million
Fig. 59 Saudi Arabia market, 2016-2028 (USD Million)
Fig. 60 UAE market, 2016-2028 (USD Million)